Product Information
THYROID 90 MG TABLET is a generic product labeled by Vitruvias Therapeutics Inc., priced at $1.0022 per EA under NDC 69680016800. Its NADAC has been published 75 times since Mar 19, 2025.
Strength
90 mg/1
Manufacturer
Vitruvias Therapeutics Inc.NDC
69680016800
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
THYROIDApproval Type
Unapproved
On Market Since
11/22/2024
Price Statistics
The NADAC for THYROID 90 MG TABLET has been published 75 times since Mar 19, 2025, and over the history we have for it it has declined 5.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0022 per EA |
|---|---|
| All-time high | $1.0635 (Apr 16, 2025) |
| All-time low | $1.0022 (Aug 19, 2026) |
| 52-week high | $1.0573 |
| 52-week low | $1.0022 |
| Median price | $1.0497 |
| Average price | $1.0461 |
| Largest weekly change | -3.5% (Jul 22, 2026) |
| Weeks tracked | 75 |
| Tracking since | Mar 19, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the THYROID market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of THYROID 90 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for THYROID 90 MG TABLET, manufactured by Vitruvias Therapeutics Inc., is $1.0022 per EA (NDC 69680016800), effective Aug 19, 2026.
How has the price of THYROID 90 MG TABLET changed over time?
Over the history we have for it, the NADAC for THYROID 90 MG TABLET has declined 5.8%. It has been tracked across 75 weekly CMS publications since Mar 19, 2025.
What are the highest and lowest recorded NADAC prices for THYROID 90 MG TABLET?
Since Mar 19, 2025, the NADAC for THYROID 90 MG TABLET has ranged from a low of $1.0022 (Aug 19, 2026) to a high of $1.0635 (Apr 16, 2025), with a median of $1.0497 per EA.
Are there cheaper alternatives to THYROID 90 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of THYROID 90 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures THYROID 90 MG TABLET?
THYROID 90 MG TABLET (NDC 69680016800) is labeled by Vitruvias Therapeutics Inc., and CMS classifies it as a generic product.